GSE162696 L-13 2 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE162696_L-13_2_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE162696_L-13_2_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE162696_L-13_2_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE162696_L-13_2_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

TXNRD1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 2367

Gene

uncharacterized LOC101929130

Gene

long intergenic non-protein coding RNA 2617

Gene

CLLU1 antisense RNA 1

Gene

R3H domain containing 2 pseudogene 2

Gene

long intergenic non-protein coding RNA 1994

Gene

adenosylhomocysteinase pseudogene 7

Gene

ALG1 like 10, pseudogene

Gene

arachidonate 15-lipoxygenase pseudogene 2

  • Gene

    TXNRD1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 2367


  • Gene

    uncharacterized LOC101929130


  • Gene

    long intergenic non-protein coding RNA 2617


  • Gene

    CLLU1 antisense RNA 1


  • Gene

    R3H domain containing 2 pseudogene 2


  • Gene

    long intergenic non-protein coding RNA 1994


  • Gene

    adenosylhomocysteinase pseudogene 7


  • Gene

    ALG1 like 10, pseudogene


  • Gene

    arachidonate 15-lipoxygenase pseudogene 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.